(19)
(11) EP 2 951 172 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
02.08.2017 Bulletin 2017/31

(45) Mention of the grant of the patent:
29.03.2017 Bulletin 2017/13

(21) Application number: 14704532.2

(22) Date of filing: 27.01.2014
(51) International Patent Classification (IPC): 
C07D 405/12(2006.01)
A61P 9/00(2006.01)
A61P 15/00(2006.01)
 A61K 31/443(2006.01)
A61P 11/00(2006.01)
A61P 25/00(2006.01)
(86) International application number:
PCT/EP2014/051546
(87) International publication number:
WO 2014/118133 (07.08.2014 Gazette 2014/32)

(54)

PYRIDINE DERIVATIVES AS SOFT ROCK INHIBITORS

PYRIDIN-DERIVATE VERWENDBAR ALS WEICHE ROCK-INHIBITOREN

DÉRIVÉS DE PYRIDINE EN TANT QU'INHIBITEURS DE ROCK TENDRES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 29.01.2013 EP 13153094
27.02.2013 GB 201303494

(43) Date of publication of application:
09.12.2015 Bulletin 2015/50

(73) Proprietor: Redx Pharma Plc
Alderley Edge, Cheshire SK10 4TG (GB)

(72) Inventors:
  • BOLAND, Sandro
    B-3590 Diepenbeek (BE)
  • BOURIN, Arnaud
    B-3590 Diepenbeek (BE)
  • DEFERT, Olivier
    B-3590 Diepenbeek (BE)
  • LEYSEN, Dirk
    B-3590 Diepenbeek (BE)

(74) Representative: HGF Limited 
1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)


(56) References cited: : 
WO-A1-2011/107608
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).